FORTBILDUNG: THEMENHEFTTEIL 02 / 2026 KINDERÄRZTE. SCHWEIZ 28 58 Mughal, S., Andújar-Sánchez, F., Sabater-Arcis, M., Garrabou, G., Fernández-Solà, J., Alegre-Martin, J., Sanmartin-Sentañes, R., Castro-Marrero, J., Esteve-Codina, A., Casals, E. and Fernández- Costa, J.M., 2025. Metabolic adaptation and fragility in healthy 3D in vitro skeletal muscle tissues exposed to chronic fatigue syndrome and Long COVID-19 sera. Biofabrication, 17(4), p.045006. 59 Peppercorn, K.; Edgar, C. D.; Kleffmann, T.; Tate, W. P. «A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome». Scientific Reports 2023;13(1):22068. doi.org/10.1038/s41598-023-49402-9 (abgerufen am 18. Mai 2026). 60 Kujawski, S.; Słomko, J.; Hodges, L.; et al. «Post-Exertional Malaise May Be Related to Central Blood Pressure, Sympathetic Activity and Mental Fatigue in Chronic Fatigue Syndrome Patients». Journal of Clinical Medicine 2021;10(11):2327. doi.org/10.3390/ jcm10112327 (abgerufen am 18. Mai 2026). 61 Donadio, V.; Incensi, A.; Furia, A.; et al. «Small fiber neuropathy associated with COVID-19 infection and vaccination: A prospective case-control study». European Journal of Neurology 2025;32(1):e16538. doi.org/10.1111/ene.16538 (abgerufen am 18. Mai 2026). 62 Wong, A. C.; Devason, A. S.; Umana, I. C.; et al. «Serotonin reduction in post-acute sequelae of viral infection». Cell 2023;186(22):4851–4867.e20. doi.org/10.1016/j. cell.2023.09.013 (abgerufen am 18. Mai 2026). 63 Klein, J.; Wood, J.; Jaycox, J. R.; et al. «Distinguishing features of long COVID identified through immune profiling». Nature 2023;623(7985):139–148. doi.org/10.1038/s41586-023-06651-y (abgerufen am 18. Mai 2026). 64 Cervia-Hasler, C.; Brüningk, S. C.; Hoch, T.; et al. «Persistent complement dysregulation with signs of thromboinflammation in active Long Covid». Science 2024;383(6680):eadg7942. doi.org/10.1126/science.adg7942 (abgerufen am 18. Mai 2026). 65 Mughal, S., Andújar-Sánchez, F., Sabater-Arcis, M., Garrabou, G., Fernández-Solà, J., Alegre-Martin, J., Sanmartin-Sentañes, R., Castro-Marrero, J., Esteve-Codina, A., Casals, E. and Fernández- Costa, J.M., 2025. Metabolic adaptation and fragility in healthy 3D in vitro skeletal muscle tissues exposed to chronic fatigue syndrome and Long COVID-19 sera. Biofabrication, 17(4), p.045006. 66 Singh, S. J.; Daynes, E.; McAuley, H. J. C.; et al. «Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review». European Respiratory Review 2023;32(170):230110. doi.org/10.1183/16000617.0110-2023 (abgerufen am 18. Mai 2026). 67 Global Burden of Disease Long COVID Collaborators; Hanson, S. Wulf; Abbafati, C.; et al. «Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021». JAMA 2022;328(16):1604–1615. doi.org/10.1001/ jama.2022.18931 (abgerufen am 18. Mai 2026). 68 Gross, R. S.; Thaweethai, T.; Salisbury, A. L.; et al. «Characterizing Long COVID Symptoms During Early Childhood». JAMA Pediatrics 2025;179(7):781–792. doi.org/10.1001/jamapediatrics.2025.1066 (abgerufen am 18. Mai 2026). 69 Gross, R. S.; Thaweethai, T.; Salisbury, A. L.; et al. «Characterizing Long COVID Symptoms During Early Childhood». JAMA Pediatrics 2025;179(7):781–792. doi.org/10.1001/jamapediatrics.2025.1066 (abgerufen am 18. Mai 2026). 70 Gross, R. S.; Thaweethai, T.; Kleinman, L. C.; et al. «Characterizing Long COVID in Children and Adolescents». JAMA 2024;332(14):1174–1188. doi.org/10.1001/jama.2024.12747 (abgerufen am 18. Mai 2026). 71 Gross, R. S.; Thaweethai, T.; Kleinman, L. C.; et al. «Characterizing Long COVID in Children and Adolescents». JAMA 2024;332(14):1174–1188. doi.org/10.1001/jama.2024.12747 (abgerufen am 18. Mai 2026). 72 World Health Organization. «A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021». WHO, 2021. WHO Reference Number: WHO/2019-nCoV/Post_ COVID-19_condition/Clinical_case_definition/2021.1. (abgerufen am 18. Mai 2026). 73 Conroy, K. E.; Islam, M. F.; Jason, L. A. «Evaluating case diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): toward an empirical case definition». Disability and Rehabilitation 2023;45(5):840–847. doi.org/10.1080/09638 288.2022.2043462 (abgerufen am 18. Mai 2026). 74 Gamper, L. «Chronic Fatigue Syndrome bei Kindern und Jugendlichen – mehr als nur Müdigkeit». Paediatrica, 16.12.2019. 75 Follmann, D.; Janes, H. E.; Buhule, O. D.; et al. «Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial». Annals of Internal Medicine 2022;175(9):1258–1265. doi.org/10.7326/M22-1300 (abgerufen am 18. Mai 2026). 76 Krutikov, M.; Palmer, T.; Tut, G.; et al. «Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England». The Lancet Healthy Longevity 2022;3(1):e13–e21. doi.org/10.1016/ S2666-7568(21)00282-8 (abgerufen am 18. Mai 2026). 77 Chu, C.; Schönbrunn, A.; Elitok, S.; et al. «T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells». Clinica Chimica Acta 2022;532:130–136. doi.org/10.1016/j. cca.2022.05.025 (abgerufen am 18. Mai 2026). 78 Grist, J. T.; Collier, G. J.; Walters, H.; et al. «Lung Abnormalities Detected with Hyperpolarized 129Xe MRI in Patients with Long COVID». Radiology 2022;305(3):709–717. doi.org/10.1148/ radiol.220069 (abgerufen am 18. Mai 2026). 79 Khan, M. S.; Miller, A. J.; Ejaz, A.; et al. «Cerebral Blood Flow in Orthostatic Intolerance». Journal of the American Heart Association 2025;14(3):e036752. doi.org/10.1161/JAHA.124.036752 (abgerufen am 18. Mai 2026). 80 Fleischer, M.; Szepanowski, F.; Tovar, M.; et al. «Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients». Neurology and Therapy 2022;11:1637–1657. 81 Guedj, E.; Campion, J. Y.; Dudouet, P.; et al. «18F-FDG brain PET hypometabolism in patients with long COVID». European Journal of Nuclear Medicine and Molecular Imaging 2021;48(9):2823– 2833. doi.org/10.1007/s00259-021-05215-4 (abgerufen am 18. Mai 2026). 82 Stein, S. R.; Ramelli, S. C.; Grazioli, A.; et al. «SARS-CoV-2 infection and persistence in the human body and brain at autopsy». Nature 2022;612(7941):758–763. doi:10.1038/s41586-02205542-y. (abgerufen am 18. Mai 2026). 83 Ernst, T.; Ryan, M. C.; Liang, H. J.; et al. «Neuronal and Glial Metabolite Abnormalities in Participants With Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton Magnetic Resonance Spectroscopy Study». The Journal of Infectious Diseases 2023;228(11):1559–1570. doi.org/10.1093/infdis/ jiad309 (abgerufen am 18. Mai 2026). 84 Li, J.; Zhou, Y.; Ma, J.; et al. «The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID». Signal Transduction and Targeted Therapy 2023;8(1):416. doi.org/10.1038/s41392-023-01640-z (abgerufen am 18. Mai 2026). 85 Grach, S. L.; Seltzer, J.; Chon, T. Y.; Ganesh, R. «Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome». Mayo Clinic Proceedings 2023;98(10):1544–1551. doi.org/10.1016/j.mayocp.2023.07.032 (abgerufen am 18. Mai 2026). 86 Scheibenbogen, C.; Bellmann-Strobl, J.; Reißhauer, A.; Maier, A.; Veauthier, C.; Schmidt, D.; Behrends, U. «Myalgische Enzephalomyelitis/Chronisches Fatigue-Syndrom: Interdisziplinär versorgen». Deutsches Ärzteblatt 2023;120(20):A-908/B-780.
RkJQdWJsaXNoZXIy MjYwNzMx